This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
Cytokeratin Pan Type I/II Antibody Cocktail
catalog :
MA1-82041
quantity :
100 µL
price :
US 259
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
AE1/AE3
reactivity :
human, mouse, pigs
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
citations: 97
Reference |
---|
De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
|
Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
|
Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
|
Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
|
Derici S, Sevinc A, Harmancioglu O, Saydam S, Kocdor M, Aksoy S, et al. Validation of three breast cancer nomograms and a new formula for predicting non-sentinel lymph node status. Asian Pac J Cancer Prev. 2012;13:6181-5 pubmed
|
Katayama M, Fukuda T, Narabara K, Abe A, Kondo Y. Localization of estrogen receptor in the central lymphoid organs of chickens during the late stage of embryogenesis. Biosci Biotechnol Biochem. 2012;76:2003-7 pubmed
|
Wei T, Guo T, Li W, Hou S, Kingery W, Clark J. Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain. J Neuroinflammation. 2012;9:181 pubmed
|
Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
|
Horváth E, Krenacs L, Bagdi E, Pávai Z, Macarie I, Nagy E, et al. Plasmoblastic lymphoma associated with human immunodeficiency virus. Rom J Morphol Embryol. 2008;49:309-14 pubmed
|
Kefeli M, Yildiz L, Aydin O, Kandemir B, Faik Yilmaz A. Chromophobe renal cell carcinoma with osseous metaplasia containing fatty bone marrow element: a case report. Pathol Res Pract. 2007;203:749-52 pubmed
|
Vardar E, Gunlusoy B, Arslan M, Kececi S. Myointimoma of the glans penis. Pathol Int. 2007;57:158-61 pubmed
|
Keskek M, Balas S, Gokoz A, Sayek I. Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer. Surg Today. 2006;36:1047-52 pubmed
|
Aydin N, Celik O, Hascalik S, Edali M. Atypical reactive ovarian surface epithelium, a pitfall in pathologic assessment. Int J Gynecol Cancer. 2006;16 Suppl 1:207-10 pubmed
|
Niku M, Ekman A, Pessa Morikawa T, Iivanainen A. Identification of major cell types in paraffin sections of bovine tissues. BMC Vet Res. 2006;2:5 pubmed
|
Yamamoto H, Oda Y, Yao T, Oiwa T, Kobayashi C, Tamiya S, et al. Malignant perivascular epithelioid cell tumor of the colon: report of a case with molecular analysis. Pathol Int. 2006;56:46-50 pubmed
|
Yesim G, Gupse T, Zafer U, Ahmet A. Mesenchymal hamartoma of the liver in adulthood: immunohistochemical profiles, clinical and histopathological features in two patients. J Hepatobiliary Pancreat Surg. 2005;12:502-7 pubmed
|
Daum O, Sima R, Mukensnabl P, Vanecek T, Brouckova M, Benes Z, et al. Pigmented solid-pseudopapillary neoplasm of the pancreas. Pathol Int. 2005;55:280-4 pubmed
|
Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
|
Boom H, De Heer E, van der Wal A, Kruidenier L, de Fijter J, Benediktsson H, et al. The absence of delayed graft function is predicted by the presence of manganese-superoxide dismutase in distal tubules of renal allografts. Transplantation. 2005;79:946-52 pubmed
|
Acikalin M, Tel N, Oner U, Pasaoglu O, Donmez T. Epithelioid angiomyolipoma of the kidney. Int J Urol. 2005;12:204-7 pubmed
|
Acikalin M, Kabukcuoglu S, Can C. Sarcomatoid carcinoma of the renal pelvis with giant cell tumor-like features: case report with immunohistochemical findings. Int J Urol. 2005;12:199-203 pubmed
|
Bisceglia M, Ludovico O, Di Mattia A, Ben Dor D, Sandbank J, Pasquinelli G, et al. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol. 2004;12:231-43 pubmed
|
Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
|
Mukhopadhyay S, Damron T, Valente A. Recurrent amyloidoma of soft tissue with exuberant giant cell reaction. Arch Pathol Lab Med. 2003;127:1609-11 pubmed
|
Ihtiyar E, Isiksoy S, Algin C, Sahin A, Erkasap S, Yasar B. Ectopic thyroid in the gallbladder: report of a case. Surg Today. 2003;33:777-80 pubmed
|
Vrolijk H, Sloos W, Mesker W, Franken P, Fodde R, Morreau H, et al. Automated acquisition of stained tissue microarrays for high-throughput evaluation of molecular targets. J Mol Diagn. 2003;5:160-7 pubmed
|
Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed
|
product information
Product Type :
Antibody
Product Name :
Cytokeratin Pan Type I/II Antibody Cocktail
Catalog # :
MA1-82041
Quantity :
100 µL
Price :
US 259
Clonality :
Cocktail
Purity :
purified
Host :
Mouse
Reactivity :
Human, Mouse, Non-human primate, Porcine, Shrew
Applications :
Immunocytochemistry: 1:100, Immunofluorescence: 1:100, Immunohistochemistry (Frozen): 1:10-1:40, Immunohistochemistry (Paraffin): 1:10-1:40, Western Blot: 1:200-1:1000
Species :
Human, Mouse, Non-human primate, Porcine, Shrew
Clone :
AE1/AE3
Isotype :
IgG1
Storage :
4°C or -20°C if preferred
Description :
Cytokeratin pan is part of a subfamily of intermediate filament proteins that are characterized by remarkable biochemical diversity, and represented in human epithelial tissues by at least 20 different polypeptides. Cytokeratins range in molecular weight between 40 kDa- 68 kDa, and an isoelectric pH between 4.9-7.8. The individual human cytokeratins are numbered 1 to 20. The various epithelia in the human body usually express cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. The composition of cytokeratin pairs vary with the epithelial cell type, stage of differentiation, cellular growth environment, and disease state. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis.
Immunogen :
Human epidermal keratins.
Format :
Liquid
Applications w/Dilutions :
Immunocytochemistry: 1:100, Immunofluorescence: 1:100, Immunohistochemistry (Frozen): 1:10-1:40, Immunohistochemistry (Paraffin): 1:10-1:40, Western Blot: 1:200-1:1000
Aliases :
2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kda cytokeratin; 60-kDa keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; AI324768; AI528832; AI626930; AI663979; AL022697; AU019895; AW108092; AW146334; BB005427; BCIE; BIE; Card2; Cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; cytokeratin-14; Cytokeratin-15; cytokeratin-16; Cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; EBS2; EBS3; EBS4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; epithelial keratin-1; Epithelial keratin-2e; EPPK; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6C; K6D; K7; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 13; keratin 13, type I; keratin 13-like; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14-like; keratin 15; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 17; keratin 17, type I; keratin 17-like; keratin 18; keratin 18, type I; keratin 18-like; keratin 19; keratin 19, type I; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin 5-like; keratin 6 alpha; keratin 6A; keratin 6A, , type II; keratin 6A, type II; keratin 6A-like; keratin 6B; keratin 7; keratin 7, type II; keratin 75; keratin 8; keratin 8, type II; keratin 86; keratin complex 1, acidic, gene 10; keratin complex 1, acidic, gene 13; keratin complex 1, acidic, gene 14; keratin complex 1, acidic, gene 15; keratin complex 1, acidic, gene 16; keratin complex 1, acidic, gene 17; keratin complex 1, acidic, gene 18; keratin complex 1, acidic, gene 19; keratin complex 2, basic, gene 1; keratin complex 2, basic, gene 17; keratin comp
company information

Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments